1. Home
  2. MNKD vs CVI Comparison

MNKD vs CVI Comparison

Compare MNKD & CVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • CVI
  • Stock Information
  • Founded
  • MNKD 1991
  • CVI 1906
  • Country
  • MNKD United States
  • CVI United States
  • Employees
  • MNKD N/A
  • CVI N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • CVI Integrated oil Companies
  • Sector
  • MNKD Health Care
  • CVI Energy
  • Exchange
  • MNKD Nasdaq
  • CVI Nasdaq
  • Market Cap
  • MNKD 1.6B
  • CVI 1.9B
  • IPO Year
  • MNKD 2004
  • CVI 2007
  • Fundamental
  • Price
  • MNKD $5.03
  • CVI $19.41
  • Analyst Decision
  • MNKD Buy
  • CVI Sell
  • Analyst Count
  • MNKD 6
  • CVI 5
  • Target Price
  • MNKD $8.92
  • CVI $22.00
  • AVG Volume (30 Days)
  • MNKD 1.9M
  • CVI 1.0M
  • Earning Date
  • MNKD 05-07-2025
  • CVI 04-28-2025
  • Dividend Yield
  • MNKD N/A
  • CVI 5.16%
  • EPS Growth
  • MNKD N/A
  • CVI N/A
  • EPS
  • MNKD 0.10
  • CVI 0.07
  • Revenue
  • MNKD $285,504,000.00
  • CVI $7,610,000,000.00
  • Revenue This Year
  • MNKD $14.66
  • CVI N/A
  • Revenue Next Year
  • MNKD $14.27
  • CVI $7.27
  • P/E Ratio
  • MNKD $50.50
  • CVI $278.53
  • Revenue Growth
  • MNKD 43.50
  • CVI N/A
  • 52 Week Low
  • MNKD $3.97
  • CVI $15.60
  • 52 Week High
  • MNKD $7.63
  • CVI $38.07
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 37.28
  • CVI 47.13
  • Support Level
  • MNKD $5.16
  • CVI $19.66
  • Resistance Level
  • MNKD $5.12
  • CVI $20.42
  • Average True Range (ATR)
  • MNKD 0.14
  • CVI 0.85
  • MACD
  • MNKD 0.01
  • CVI -0.05
  • Stochastic Oscillator
  • MNKD 25.45
  • CVI 41.81

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About CVI CVR Energy Inc.

CVR Energy Inc is a holding company that engages in petroleum refining and nitrogen fertilizer manufacturing through its subsidiaries. subsidiaries include several complex full-coking crude oil refineries, along with a crude oil gathering system, pipelines and storage tanks, and marketing and supply. The company's refineries can process blends of a variety of crude oil ranging from heavy sour to light sweet crude oil. Crude oil for CVR's refineries is supplied through its wholly-owned gathering system and pipeline. From its refineries, CVR supplies products through tanker trucks directly to customers located in close geographic proximity and customers at throughput terminals. The company's customers include retailers, railroads, and farm cooperatives.

Share on Social Networks: